WHO Releases New Recommendations on Human Genome Editing
The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.
WHO Releases New Recommendations on Human Genome Editing
WHO Releases New Recommendations on Human Genome Editing
The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.
The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.
Removal of the 14-day limit for culturing human embryos is one of the main changes in the revised recommendations from the International Society for Stem Cell Research.
A new ruling removes the requirement that grants and proposals using the material receive approval from an ethical review board, reverting to the process in place before 2019.
The agency says that to “reset” the advisory boards and bolster “scientific integrity,” more than 40 advisors appointed during former President Donald Trump’s tenure have been let go.
An investigation reveals that the government is developing technology to try to reconstruct a person’s appearance based on a genetic sample, raising concerns for the rights of Muslim minority groups in the country.
Building simulations based on real genetic data, researchers conclude Gattaca-like tactics to choose the traits of future offspring would yield little payoff.
Nearly two dozen higher education groups warn the government to be cautious when advising US research universities to keep an eye on students and faculty with ties to certain Chinese institutions.
After several high-profile cases, the country’s government is creating a board to oversee and investigate all serious allegations of scientific misconduct.
A spending bill approved by a House committee would require the agency to “accelerate” the replacement of nonhuman primates in laboratories starting in October.
Authors of a new paper take issue with revisions to regulations on biospecimen research enacted last month, and argue that cell lines should be treated differently from other biospecimens.